- Home
- EOSEW vs IDYA Comparison
EOSEW vs IDYA Comparison
Compare EOSEW & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOSEW
- IDYA
- Stock Information
- Founded
- EOSEW N/A
- IDYA 2015
- Country
- EOSEW United States
- IDYA United States
- Employees
- EOSEW 430
- IDYA N/A
- Industry
- EOSEW Industrial Machinery/Components
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- EOSEW Miscellaneous
- IDYA Health Care
- Exchange
- EOSEW Nasdaq
- IDYA Nasdaq
- Market Cap
- EOSEW N/A
- IDYA 1.9B
- IPO Year
- EOSEW N/A
- IDYA 2019
- Fundamental
- Price
- EOSEW $0.50
- IDYA $21.17
- Analyst Decision
- EOSEW
- IDYA Strong Buy
- Analyst Count
- EOSEW 0
- IDYA 13
- Target Price
- EOSEW N/A
- IDYA $53.42
- AVG Volume (30 Days)
- EOSEW 166.0K
- IDYA 1.0M
- Earning Date
- EOSEW 03-05-2025
- IDYA 08-05-2025
- Dividend Yield
- EOSEW N/A
- IDYA N/A
- EPS Growth
- EOSEW N/A
- IDYA N/A
- EPS
- EOSEW N/A
- IDYA N/A
- Revenue
- EOSEW $14,963,000.00
- IDYA $7,000,000.00
- Revenue This Year
- EOSEW N/A
- IDYA $101.20
- Revenue Next Year
- EOSEW N/A
- IDYA $286.70
- P/E Ratio
- EOSEW N/A
- IDYA N/A
- Revenue Growth
- EOSEW 20.34
- IDYA N/A
- 52 Week Low
- EOSEW $0.07
- IDYA $13.45
- 52 Week High
- EOSEW $1.61
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- EOSEW 59.11
- IDYA 49.72
- Support Level
- EOSEW $0.32
- IDYA $20.50
- Resistance Level
- EOSEW $0.44
- IDYA $22.32
- Average True Range (ATR)
- EOSEW 0.06
- IDYA 0.93
- MACD
- EOSEW 0.02
- IDYA -0.16
- Stochastic Oscillator
- EOSEW 72.37
- IDYA 28.31
About EOSEW Eos Energy Enterprises Inc. Warrant
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.